Keros Therapeutics Inc (KROS) — Capital Reinvestment Ratio
Keros Therapeutics Inc (KROS) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow ($3.25 Million) in capital expenditures ($132.00K). See how leveraged is Keros Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Keros Therapeutics Inc Capital Reinvestment Ratio (2018–2018)
This chart tracks Keros Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Keros Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Keros Therapeutics Inc (2018–2018)
Year-by-year Capital Reinvestment Ratio for Keros Therapeutics Inc from 2018 to 2018. For live market cap and broader valuation context, see KROS company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.03x | $7.04 Million | $217.00K | — |